Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
Go back to Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial| (NASDAQ: PLRZ) | Delayed: 10.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.66 | 52 Week High | $ | |||
| Open | $10.66 | 52 Week Low | $ | |||
| Day High | $10.66 | P/E | N/A | |||
| Day Low | $10.66 | EPS | $ | |||
| Volume | 1,014 | |||||

